Experienced in Disseminated Intravascular Coagulation

Jie Y. Hu

No 54, Youdian Road, 
Hangzhou, CN 
Experienced in Disseminated Intravascular Coagulation
No 54, Youdian Road, 
Hangzhou, CN 
OverviewLocationsClinical Research

Overview

Jie Hu practices in Hangzhou, China. Hu is rated as an Experienced expert by MediFind in the treatment of Disseminated Intravascular Coagulation. Their top areas of expertise are Supravalvular Aortic Stenosis, Lung Cancer, Liver Cancer, Hepato-Pancreato-Biliary Surgery, and Endoscopy.

Their clinical research consists of co-authoring 1206 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Disseminated Intravascular Coagulation.

Locations

No 54, Youdian Road, Hangzhou, China
Other Locations
101 Longmian Avenue, Nanjing, 211166, China
26 Hexing Road, Harbin, 150040, China
79 Qingchun Road, Hangzhou, 310003, China
361 East Zhongshan Road, Shijiazhuang, 050017, China
No. 201-209, Hubin South Road, Xiamen, 361004, China
Dalian Road 149, Zunyi, China
No. 54, Youdian Road, Hangzhou, 310006, China
No. 382, Wuyi Road, Taiyuan, China
800 Dongchuan Road, Shanghai, 200240, China
1678 Dongfang Road, Dongfang, China
No. 81 Meishan Road, Hefei, 230032, China
No. 28, Fuxing Road, Haidian, 100853, China
No. 382 Wuyi Road, Taiyuan, 030001, China
No.569 Xinsi Road, Xi'an, 710038, China
Dr. 361 East Zhongshan Road, Shijiazhuang, 050017, China
Wushan Road, Guangzhou, 510642, China
No. 12 Mid Wulumuqi Rd, Shanghai, 200040, China
No. 88 Jiefang Road, Hangzhou, 310009, China
99 Shangda Road, Shanghai, 200444, China
No. 45 Changchun Road, Beijing, 100053, China
1 Xinsi Road, Xi'an, 710038, China
28thFuxing Road, Haidian, 100853, China
2600 Dong Hai Avenue, Bengbu, 233030, China
Xueyuan Road, Wenzhou, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including Rearranged in Transfection (RET) Fusion-Positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation
A Phase 2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including Rearranged in Transfection (RET) Fusion-Positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drug: Selpercatinib
Study Phase: Phase 2

1206 Total Publications

Integrative Multi-Omics Features Stratify Metabolic and Immune Subtypes in Glioma.
Integrative Multi-Omics Features Stratify Metabolic and Immune Subtypes in Glioma.
Journal: JCO precision oncology
Published: September 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hu's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 148 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile